Skip to main content

Table 2 Patient characteristics of the cohort recruited in Mannheim

From: The EEF1A2 gene expression as risk predictor in localized prostate cancer

Parameter

n

Patients with PCa

59 (mean age 62.9 ± 6.9)

T stage

 T1

 T2

23

 T3

33

 T4

3

N stage

 N1

5

 N0

47

 Nx

7

Gleason score

 3

1

 4

0

 5

10

 6

15

 7a

15

 7b

4

 8

5

 9

3

 10

2

n.a. due to prior antihormonal therapy

4

average serum PSA level

13.3 ng/ml (2.8–73.0 ng/ml)

Control patients

15 (mean age 67.2 ± 11.3)